Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 574 record(s)

Req # A-2016-001806

All information relating to the Ethicon’s Physiomesh, including documents relating to Ethicon’s application for approval of the Physiomesh in Canada, Ethicon’s development and testing of the Physiomesh, Health Canada’s testing and approval of the Physiomesh and the recall of the Physiomesh

Organization: Health Canada

1148 page(s)
March 2023

Req # Tous les documents relatifs à

All records as it pertains to Natural Product Number (NPN) 800063761 (Parodontax Original).

Organization: Health Canada

1470 page(s)
March 2023

Req # A-2017-000001

All releasable product information for the following Natural Product Numbers (NPNs): 80043696, 80046986, 80047226, 80047528, 80049401, 80053145, 80056103, 80056346, 80060345, 80070583, 80071855, 80075493, 80075688, 80067260, 80073271.

Organization: Health Canada

1676 page(s)
March 2023

Req # A-2017-000107

The New Drug Submission, Supplemental New Drug Submission or similar submission from the drug company to obtain approval for using Anafranil / Altius Clomipramine in the treatment of Obsessive Compulsive Disorder. The medical review of that aforementioned submission performed by Health Canada or by someone contracted by Health Canada.

Organization: Health Canada

132 page(s)
March 2023

Req # A-2018-000175

Drug submission information for Tylenol Extra Strength Gel Caps 500 mg Drug Identification Number (DIN) 00863270.

Organization: Health Canada

280 page(s)
March 2023

Req # A-2018-001598

Module 1 along with the reviewers note of the INTELLI-SEVELAMER 800 MG tablets New Drug Submission (NDS) Control No: 222726 - DIN 02484110 for INTELLIPHARM INC.

Organization: Health Canada

111 page(s)
March 2023

Req # A-2019-001941

Letters, notices, and email correspondence issued to Cannabis Act licence holders regarding non-compliance with the promotion prohibitions under the Cannabis Act between January 1, 2019 and February 1, 2020.

Organization: Health Canada

30 page(s)
March 2023

Req # A-2021-000235

All briefing provided to the Minister of Health regarding designated quarantine facilities for travellers. Timeframe: November 1, 2019 to May 17, 2021.

Organization: Health Canada

34 page(s)
March 2023

Req # A-2021-000562

The documentation or studies that Health Canada based itself on to issue incident report RA-75309, dated April 2, 2021, titled. All documents containing the results from the preliminary analysis completed by Health Canada in this regard.

Organization: Health Canada

57 page(s)
March 2023

Req # A-2021-001315

Summary basis of decision and Instruction For Use (IFU) for Mirasol Pathogen Reduction Technology System model No. 106324.

Organization: Health Canada

302 page(s)
March 2023

What's new in open government?

Date modified: